Could cause temporary or reversible harm; serious harm is unlikely.
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
| Brand name | MONTELUKAST SODIUM |
| Generic name | MONTELUKAST SODIUM |
| Active ingredient(s) | MONTELUKAST SODIUM |
| Distributed by / for | Camber Pharmaceuticals, Inc., Piscataway, NJ 08854 |
| NDC | 31722-726-30 |
| Full product label | Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30. |
| Recalling firm | Hetero Labs Limited Unit V |
| Distribution | Nationwide in the USA |
| Quantity | 98,016 bottles |
| Recall initiated | 2018-08-20 |
| Report date | 2018-10-03 |
| Recall completed | 2021-11-05 |
| Recall number | D-1213-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Jadcherla Mandal, Mahaboob Nagar India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗